{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:27:37Z","timestamp":1749097657119},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,30]]},"DOI":"10.7759\/cureus.70546","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:39:06Z","timestamp":1727717946000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical, Lab, and Radiological Evolution of an Adult Patient With Unilateral Cortical Lesion in Anti-Myelin Oligodendrocyte Glycoprotein (MOG)-Associated Encephalitis With Seizures and Anti-Glial Fibrillary Acidic Protein (GFAP) Positive Antibodies"],"prefix":"10.7759","author":[{"given":"Michail","family":"Papantoniou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Panagou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Kanavouras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000060","article-title":"MOG antibody-associated diseases","volume":"2","author":"Reindl M","year":"2015","unstructured":"Reindl M, Rostasy K. MOG antibody-associated diseases. Neurol Neuroimmunol Neuroinflamm. 2015, 2:e60. 10.1212\/NXI.0000000000000060","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00217","article-title":"MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder","volume":"9","author":"Dos Passos GR","year":"2018","unstructured":"Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK. MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol. 2018, 9:217. 10.3389\/fneur.2018.00217","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-020-01069-9","article-title":"Gerstmann syndrome","volume":"20","author":"Ardila A","year":"2020","unstructured":"Ardila A. Gerstmann syndrome. Curr Neurol Neurosci Rep. 2020, 20:48. 10.1007\/s11910-020-01069-9","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231198754","article-title":"Validation of the International MOGAD Panel proposed criteria","volume":"29","author":"Kim KH","year":"2023","unstructured":"Kim KH, Kim SH, Park NY, Hyun JW, Kim HJ. Validation of the International MOGAD Panel proposed criteria. Mult Scler. 2023, 29:1680-1683. 10.1177\/13524585231198754","journal-title":"Mult Scler"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102759","article-title":"FLAMES: a novel burning entity in MOG IgG associated disease","volume":"49","author":"Jain K","year":"2021","unstructured":"Jain K, Cherian A, Divya KP, Rajalakshmi P, Thomas B, Nandana J. FLAMES: a novel burning entity in MOG IgG associated disease. Mult Scler Relat Disord. 2021, 49:102759. 10.1016\/j.msard.2021.102759","journal-title":"Mult Scler Relat Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius S","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, et al.. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation. 2016, 13:279. 10.1186\/s12974-016-0717-1","journal-title":"J Neuroinflammation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius S","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, et al.. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016, 13:280. 10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley J","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M, et al.. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014, 71:276-283. 10.1001\/jamaneurol.2013.5857","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.24061","article-title":"MOGAD: How it differs from and resembles other neuroinflammatory disorders","volume":"216","author":"Shahriari M","year":"2021","unstructured":"Shahriari M, Sotirchos ES, Newsome SD, Yousem DM. MOGAD: How it differs from and resembles other neuroinflammatory disorders. AJR Am J Roentgenol. 2021, 216:1031-1039. 10.2214\/AJR.20.24061","journal-title":"AJR Am J Roentgenol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09869-2","article-title":"Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy","volume":"267","author":"Ding J","year":"2020","unstructured":"Ding J, Ren K, Wu J, Li H, Sun T, Yan Y, Guo J. Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy. J Neurol. 2020, 267:2589-2593. 10.1007\/s00415-020-09869-2","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02381-8","article-title":"Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgG","volume":"21","author":"Ji S","year":"2021","unstructured":"Ji S, Liu C, Bi Z, Gao H, Sun J, Bu B. Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgG. BMC Neurol. 2021, 21:348. 10.1186\/s12883-021-02381-8","journal-title":"BMC Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000236","article-title":"Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for overlapping pathophysiology","volume":"4","author":"Martin AJ","year":"2022","unstructured":"Martin AJ, Strathdee J, Wolfe N. Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for overlapping pathophysiology. BMJ Neurol Open. 2022, 4:e000236. 10.1136\/bmjno-2021-000236","journal-title":"BMJ Neurol Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.01.036","article-title":"Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack","volume":"29","author":"Yang X","year":"2019","unstructured":"Yang X, Huang Q, Yang H, et al.. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack. Mult Scler Relat Disord. 2019, 29:94-99. 10.1016\/j.msard.2019.01.036","journal-title":"Mult Scler Relat Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001052","article-title":"Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond","volume":"35","author":"Mader S","year":"2022","unstructured":"Mader S, K\u00fcmpfel T, Meinl E. Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond. Curr Opin Neurol. 2022, 35:427-435. 10.1097\/WCO.0000000000001052","journal-title":"Curr Opin Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.94.15_supplement.862","article-title":"Adding FUEL to the FLAMES: FLAIR-variable unilateral enhancement of the leptomeninges (FUEL) in MOG-IgG-associated disease","volume":"94","author":"Budhram A","year":"2020","unstructured":"Budhram A, Kunchok A, Flanagan E. Adding FUEL to the FLAMES: FLAIR-variable unilateral enhancement of the leptomeninges (FUEL) in MOG-IgG-associated disease. Neurology. 2020, 94:15. 10.1212\/WNL.94.15_supplement.862","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00960","article-title":"The expanding clinical spectrum of myelin oligodendrocyte glycoprotein (MOG) antibody associated disease in children and adults","volume":"11","author":"Parrotta E","year":"2020","unstructured":"Parrotta E, Kister I. The expanding clinical spectrum of myelin oligodendrocyte glycoprotein (MOG) antibody associated disease in children and adults. Front Neurol. 2020, 11:960. 10.3389\/fneur.2020.00960","journal-title":"Front Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders","volume":"75","author":"L\u00f3pez-Chiriboga AS","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Majed M, Fryer J, et al.. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol. 2018, 75:1355-1363. 10.1001\/jamaneurol.2018.1814","journal-title":"JAMA Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1604404","article-title":"MOG spectrum disorders and role of MOG-antibodies in clinical practice","volume":"49","author":"Hennes EM","year":"2018","unstructured":"Hennes EM, Baumann M, Lechner C, Rost\u00e1sy K. MOG spectrum disorders and role of MOG-antibodies in clinical practice. Neuropediatrics. 2018, 49:3-11. 10.1055\/s-0037-1604404","journal-title":"Neuropediatrics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244101-clinical-lab-and-radiological-evolution-of-an-adult-patient-with-unilateral-cortical-lesion-in-anti-myelin-oligodendrocyte-glycoprotein-mog-associated-encephalitis-with-seizures-and-anti-glial-fibrillary-acidic-protein-gfap-positive-antibodies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:39:08Z","timestamp":1727717948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244101-clinical-lab-and-radiological-evolution-of-an-adult-patient-with-unilateral-cortical-lesion-in-anti-myelin-oligodendrocyte-glycoprotein-mog-associated-encephalitis-with-seizures-and-anti-glial-fibrillary-acidic-protein-gfap-positive-antibodies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.70546","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}